Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
Analytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesEureka AI à l'intérieur
Services professionnels
Témoignages clients
Blog
Rapport mondial sur l'innovation
Glossaire
Newsroom
Webinaires et formations
Frontière
Communauté d'utilisateurs
Confiance et sécurité
PatentBench
LLM
Centre d'aide
Carrières
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport A 2026 patent landscape analysis of triboelectric nanogenerator (TENG) technology: key assignees, material advances, power management IP, and emerging application domains.
Article | Rapport How do ToF and FMCW LiDAR signal processing differ for autonomous vehicles? A patent intelligence analysis of 60+ filings from Waymo, Aurora, Baidu & more.
Article | Rapport Mapping the 2026 patent landscape for underwater acoustic communication: hybrid acoustic-optical systems, AI-driven mode selection, AUV swarms, and emerging IP white spaces.
Article | Rapport Explore the NIU drug pipeline: suprachoroidal steroid delivery, anti-IL-6R biologics, IL-1β inhibitors, and gene therapy approaches shaping uveitis treatment.
Article | Rapport Explore the 2026 maglev bearing patent landscape: active magnetic bearings, Halbach-array PMBs, bearingless motors, and emerging sensorless control innovations.
Article | Rapport Explore the GCA and large vessel vasculitis drug pipeline: IL-6/IL-6R, GM-CSF, IL-17, JAK inhibitor, and anti-MCAM patent strategies analysed by PatSnap Insights.
Article | Rapport EUV and VUV light source patent landscape 2026: plasma sources, solid-state UV LEDs, far-UVC disinfection, and the key assignees shaping semiconductor lithography IP.
Article | Rapport How to reduce dark current noise in CMOS image sensors for automotive cameras — pixel-level, OB correction, temperature-adaptive, and HDR readout strategies from 50+ patents.
Article | Rapport GM-CSF inhibitors, IL-6R antibodies, CSF1R blockade, and oral kinase approaches are reshaping the RA drug pipeline for patients who fail TNF and JAK therapies.
Article | Rapport How to reduce dark current noise in CMOS image sensors for automotive cameras: pixel-level, OB-reference, temperature-adaptive, and HDR correction strategies.
Article | Rapport Patent-mapped analysis of miniaturized mass spectrometry in 2026: MEMS chip-scale instruments, high-pressure ESI, AI-driven acquisition, and key assignee strategies.
Article | Rapport Electrochemical nitrogen reduction patents are surging. Explore the 2026 ENR technology landscape: NO₃RR catalysts, direct NRR, 3D electrodes, and key assignees.
Article | Rapport How EUV mask defect inspection—phase defects, DUV wavelength gaps, pattern placement, and simulation—directly drives yield in high-volume logic manufacturing.
Article | Rapport Mapping the 2026 ENR patent landscape: NO₃RR catalysts, direct N₂ reduction, 3D-printed electrodes, and green ammonia synthesis across 80+ records from 2009–2026.
Article | Rapport How V940, BNT111, and neoantigen platforms are reshaping melanoma and NSCLC treatment. Patent signals, combination strategies, and biomarker insights analysed.